Earnings History Data for Talaris Therapeutics, Inc. (TALS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Talaris Therapeutics, Inc.
Talaris Therapeutics Inc. is a late-clinical stage cell therapy company. It involved in developing a method of allogeneic hematopoietic stem cell transplantation with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe non-malignant blood, immune and metabolic disorders. Talaris Therapeutics Inc. is based in BOSTON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-11-2022 | PM | 7:00 AM ET (Nov 10) |
TALS | Talaris Therapeutics | 62.00 | -0.46 | -0.42 | 0.00 | Talaris Therapeutics GAAP EPS of -$0.46 misses by $0.05 [11/10/2022 9:29 AM] |
1.52 | 0.09 (6.29%) |
1.41 | -0.02 (-1.40%) |
1.16 - 17.25 | 179,711 | 200,000 | 10,204 | |
| 15-08-2022 | PM | TALS | Talaris Therapeutics | 194.00 | -0.44 | -0.46 | 0.00 | Talaris Therapeutics GAAP EPS of -$0.44 [8/15/2022 8:11 AM] |
4.85 | 0.0 (0.00%) |
4.85 | 0.0 (0.00%) |
2.04 - 17.48 | 44,068 | 90,000 | 2,060 | ||
| 12-05-2022 | AH | TALS | Talaris Therapeutics | 286.00 | -0.45 | -0.35 | 0.00 | Talaris Therapeutics GAAP EPS of -$0.45 [5/12/2022 5:11 PM] |
6.78 | 0.82 (13.76%) |
0.0 | 0.0 (0.00%) |
5.75 - 19.82 | 36,630 | 30,000 | 0 | ||
| 17-03-2022 | AH | TALS | Talaris Therapeutics | 309.00 | -0.31 | -0.35 | 0.00 | Talaris Therapeutics GAAP EPS of -$1.64 [3/17/2022 5:36 PM] |
8.07 | 0.11 (1.38%) |
7.96 | 0.0 (0.00%) |
6.34 - 19.82 | 55,318 | 56,773 | 1,305 | ||
| 12-11-2021 | PM | TALS | Talaris Therapeutics, Inc. | 667.74 | -0.32 | -0.28 | 0.00 | Talaris Therapeutics EPS misses by $0.06 [11/12/2021 8:52 AM] |
15.96 | -0.02 (-0.13%) |
15.98 | 0.0 (0.00%) |
11.39 - 19.82 | 64,194 | 60,000 | 2,164 | ||
| 12-08-2021 | PM | Before the open (Aug 12) |
TALS | Talaris Therapeutics, Inc. | 576.00 | -0.41 | -0.22 | 0.00 | Talaris Therapeutics EPS misses by $0.18 [8/12/2021 7:37 AM] |
13.79 | -0.33 (-2.34%) |
13.79 | 0.0 (0.00%) |
11.41 - 19.82 | 26,122 | 20,000 | 763 | |